DIFFERENTIAL TOXICITY OF REACTIVE METABOLITES OF CLYNDAMICIN AND SULFONAMIDES IN HIV-INFECTED CELLS: INFUENCE OF HIV INFECTION ON CLYNDAMICIN TOXICITY IN VITRO

WIJSMAN, J.A., & DEKABAN, G.A.. (2005). DIFFERENTIAL TOXICITY OF REACTIVE METABOLITES OF CLYNDAMICIN AND SULFONAMIDES IN HIV-INFECTED CELLS: INFUENCE OF HIV INFECTION ON CLYNDAMICIN TOXICITY IN VITRO. JOURNAL OF CLINICAL PHARMACOLOGY, 45(-), 346-351. SID. https://sid.ir/paper/614246/en

WIJSMAN J.A., DEKABAN G.A.. DIFFERENTIAL TOXICITY OF REACTIVE METABOLITES OF CLYNDAMICIN AND SULFONAMIDES IN HIV-INFECTED CELLS: INFUENCE OF HIV INFECTION ON CLYNDAMICIN TOXICITY IN VITRO. JOURNAL OF CLINICAL PHARMACOLOGY[Internet]. 2005;45(-):346-351. Available from: https://sid.ir/paper/614246/en

J.A. WIJSMAN, and G.A. DEKABAN, “DIFFERENTIAL TOXICITY OF REACTIVE METABOLITES OF CLYNDAMICIN AND SULFONAMIDES IN HIV-INFECTED CELLS: INFUENCE OF HIV INFECTION ON CLYNDAMICIN TOXICITY IN VITRO,” JOURNAL OF CLINICAL PHARMACOLOGY, vol. 45, no. -, pp. 346–351, 2005, [Online]. Available: https://sid.ir/paper/614246/en